ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026

A novel colchicine-binding site inhibitor suppresses triple-negative breast cancer growth and metastasis and synergizes with anti-PD-L1 immunotherapy in an immunogenic cancer model.

Kelli L Adeleye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.